Search research articles
Contact Us
Filters
Showing results (111-120 of 155) with videos related to
Page
of 16
Sort By:
Cancer
|
June 5, 2003
Treatment of Philadelphia chromosome-positive chronic myelogenous leukemia with weekly polyethylene glycol formulation of interferon-alpha-2b and low-dose cytosine arabinoside
Guillermo Garcia-Manero, Moshe Talpaz, Francis J Giles, et al.
Blood
|
May 29, 2016
Impact of complete molecular response on survival in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia
Nicholas J Short, Elias Jabbour, Koji Sasaki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 8, 2004
A Phase I and pharmacokinetic study of VNP40101M, a novel sulfonylhydrazine alkylating agent, in patients with refractory leukemia
Francis Giles, Deborah Thomas, Guillermo Garcia-Manero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 2009
Characteristics associated with important clinical end points in patients with chronic lymphocytic leukemia at initial treatment
William G Wierda, Susan O'Brien, Xuemei Wang, et al.
Cancer
|
December 15, 2005
A retrospective comparison of three sequential groups of patients with Recurrent/Refractory chronic lymphocytic leukemia treated with fludarabine-based regimens
William Wierda, Susan O'brien, Stefan Faderl, et al.
American Journal of Hematology
|
April 22, 2011
Prediction model for mortality after intracranial hemorrhage in patients with leukemia
Farshid Dayyani, Sarah Schellhorn Mougalian, Kiran Naqvi, et al.
The New England Journal of Medicine
|
October 6, 2006
Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion
Alan List, Gordon Dewald, John Bennett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 16, 2005
Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia
Michael J Keating, Susan O'Brien, Maher Albitar, et al.
Cancer
|
August 28, 2003
Results of triple therapy with interferon-alpha, cytarabine, and homoharringtonine, and the impact of adding imatinib to the treatment sequence in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in early chronic phase
Susan O'Brien, Francis Giles, Moshe Talpaz, et al.
Clinical Lymphoma & Myeloma
|
December 16, 2005
T-cell prolymphocytic leukemia: a single-institution experience
Farhad Ravandi, Susan O'Brien, Dan Jones, et al.
Page
of 16
Search research articles
Search
Showing results (111-120 of 155) with videos related to
Sort By:
Page
of 16
Cancer
|
June 5, 2003
Treatment of Philadelphia chromosome-positive chronic myelogenous leukemia with weekly polyethylene glycol formulation of interferon-alpha-2b and low-dose cytosine arabinoside
Guillermo Garcia-Manero, Moshe Talpaz, Francis J Giles, et al.
Blood
|
May 29, 2016
Impact of complete molecular response on survival in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia
Nicholas J Short, Elias Jabbour, Koji Sasaki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 8, 2004
A Phase I and pharmacokinetic study of VNP40101M, a novel sulfonylhydrazine alkylating agent, in patients with refractory leukemia
Francis Giles, Deborah Thomas, Guillermo Garcia-Manero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 2009
Characteristics associated with important clinical end points in patients with chronic lymphocytic leukemia at initial treatment
William G Wierda, Susan O'Brien, Xuemei Wang, et al.
Cancer
|
December 15, 2005
A retrospective comparison of three sequential groups of patients with Recurrent/Refractory chronic lymphocytic leukemia treated with fludarabine-based regimens
William Wierda, Susan O'brien, Stefan Faderl, et al.
American Journal of Hematology
|
April 22, 2011
Prediction model for mortality after intracranial hemorrhage in patients with leukemia
Farshid Dayyani, Sarah Schellhorn Mougalian, Kiran Naqvi, et al.
The New England Journal of Medicine
|
October 6, 2006
Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion
Alan List, Gordon Dewald, John Bennett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 16, 2005
Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia
Michael J Keating, Susan O'Brien, Maher Albitar, et al.
Cancer
|
August 28, 2003
Results of triple therapy with interferon-alpha, cytarabine, and homoharringtonine, and the impact of adding imatinib to the treatment sequence in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in early chronic phase
Susan O'Brien, Francis Giles, Moshe Talpaz, et al.
Clinical Lymphoma & Myeloma
|
December 16, 2005
T-cell prolymphocytic leukemia: a single-institution experience
Farhad Ravandi, Susan O'Brien, Dan Jones, et al.
Page
of 16